FindTrial
Sign In

Evaluation of Drug Errors and Interactions among Patients with Heart Diseases in a Hospital Setting

Assessment of Medication Errors and Drug-Drug Interactions among Cardiovascular Disease Patients: A Clinical Pharmacist Perspective. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/10/095714
Enrollment
160
Registered
2025-10-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I258- Other forms of chronic ischemic heart disease

Interventions

Intervention1: Nil: Nil

Sponsors

KLE College of Pharmacy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with cardiovascular patients with or without comorbidities 2. Both male and female patients of IPD and OPD of more than 18 years of age to 70 years of age. 3.Patients who are willing to Participate

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women 2. Patients who have incomplete medication records or do not have the clinical or laboratory data needed for evaluation.

Design outcomes

Primary

MeasureTime frame
Identification of medication errors and drug-drug interactionsTimepoint: Baseline and 8 weeks—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Mandati Santhosh Reddy

KLE College of Pharmacy, Belagavi

tambeaiiravat33@gmail.com7349022785

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026